Zhangxiang H. Zhao
Guangzhou, 510632, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 17, 2023
Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature.
Journal: World journal of surgical oncology
Published: September 02, 2023
Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages.
Journal: Computational and structural biotechnology journal
Published: August 09, 2023
Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells.
Journal: British journal of cancer
Published: February 03, 2023
A genetic map of the chromatin regulators to drug response in cancer cells.
Journal: Journal of translational medicine
Published: July 10, 2022
LiqBioer: a manually curated database of cancer biomarkers in body fluid.
Journal: Database : the journal of biological databases and curation
Published: June 08, 2022
Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma.
Journal: Molecular oncology
Published: January 08, 2022
Pan-cancer multi-omics analyses reveal crosstalk between the Hippo and immune signaling pathways in the tumor microenvironment.
Journal: FEBS letters
Published: October 19, 2021
Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade.
Journal: British journal of cancer
Published: September 03, 2021
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level.
Journal: Molecular therapy. Nucleic acids
Published: July 09, 2021
Last Updated: 09/26/2026